Post-Brexit update from house builders Telford and Countryside
Updates are also expected from Tissue Regenix, Diurnal Group and Marston's
Company
LON:TRX
Tissue Regenix Group PLC is a pioneering, international medical technology company, focusing on the development of regenerative products utilising its two platform technologies, dCELL, addressing soft tissue needs, and BioRinse, providing sterile bone allografts. The company is currently helping to transform the treatment of patients in key surgical applications: biosurgery, orthopaedics (sports medicine/spine), dental, general, plastic surgery, urology/gynaecology, ophthalmology and cardiac.
255 stories · page 3 of 3
Updates are also expected from Tissue Regenix, Diurnal Group and Marston's
Investments and investor services
The market was encouraged by Tissue Regenix with the stock advancing 16% over the last five trading days.
Epistem formally changes its name, a double dose of good news for Tissue Regenix and Sound Energy's Tendrara project 'above expectations'.
Tissue Regenix agrees a three-year contract; Plexus Holding chief buys £200,000 worth of shares; Condor Gold identifies a potential gold-bearing corridor; and much more…
Main share price risers and fallers in London at 4.15pm
The medtech firm's products leave a so-called 'scaffold' which can then be used to repair wounded body parts
The think tank - the Organisation for Economic Co-operation and Development (OECD) - cut its forecast for UK growth this year to 1.7%..
Deltex Medical Group has hailed the “superb results”, Tissue Regenix beefs up its board and MySQUAR updates on the success of its first game.
The top flight dropped 65 points to 6,165 and in small-cap land the FTSE AIM 100 eased 0.5% to 3,470.
Professor Homer-Vanniasinkam is regularly invited to lecture at prestigious establishments across the world
Investments and investor services
The top flight dropped 39.92 points to 6190.87 after an ICM phone poll showed Leave taking the lead
The firm's technology removes cellular material leaving a 'scaffold' which can then be used to repair diseased or worn out body parts
The firm's technology removes cellular material from animal and human tissue leaving a 'scaffold' which can then be used to repair diseased or worn out body parts.
Archive
Scribes at Barclays give credit to the timing and strategy of First Quantum Minerals Ltd today and repeat an 'overweight' rating...
Metal Tiger plc shares shot up 25% as it told investors its transaction to invest in ZimNRG had been approved by shareholders .
Regenerative medtech Tissue Regenix Group PLC is making clear progress on all fronts, said heavyweight US broker Jefferies today, which rates the shares a 'buy'.
Archive
Metal Tiger chairman Terry buys £50,000 worth of shares in the AIM listed resources investor, news from Horse Hill and an update of Abzena's acquisitions.
It is the first time an implant using Tissue’s cell washing technology has been approved by the US Food and Drug Administration.
Archive
A pivotal day for mining investor Metal Tiger, "rapid progress" for Ariana Resources and a new director at Oilex.
Distin is a specialist in building sales through targeted marketing and has worked for a number of other US companies.
The posters were written by opinion leaders in the field and selected by a peer review committee.
Archive
Junior mining stocks featured prominently on Tuesday
It is the first commercial application of the cell washing technology, dCELL, in heart valves.
Archive
Medical technology and pharma firms stepped forward today. Woundcare specialist Tissue Regenix saw shares rise over 9%...
Major share price risers and fallers today at 4.15pm
Jonathan Glenn has run inhaler specialist Consort since 2007 and previously held senior financial roles across the medical industry
The strict selection criteria meant that there was only a small pool of patients that could be considered
Put simply, Tissue Regenix takes a tendon or cartilage – either from a human or from a pig – treats it and uses it to replace damaged tissue within the body.
Tissue has developed a skin graft product, a tendon replacement product as well as heart valves.
Investments and investor services
The FTSE100, which had been just slightly lower at lunch, eased further, ending the day at 6,228, a drop of 46 points
Investments and investor services
Stratmin Global, Tertiary Minerals and Fastjet also had news out on Friday
The UK’s main index lost around 8 points to 6,266
FTSE 100 dipped 10 points to 6,264, with similar–sized falls in France and Germany
ACL ruptures are the second most common knee injury with around 900,000 procedures a year performed in Europe and the US. The main surgical options for this type of injury are limited to taking tissue from the patient, human donor material
Investments and investor services
There were a number of news items out from the small caps to kick-off the week.
DermaPure is now available under Medicare, the US’s heathcare plan for the elderly, to some 37 mln people in in 31 US states.
The management from e-Therapeutics (LON:ETX), Ergomed (LON:ERGO), Tissue Regenix (LON:TRX) and TekCapital (LON:TEK) will be updating investors on current developments and future prospects.
Witan one of the UK’s oldest investment trusts, and Woodford Patient Capital Trust, which listed in April, reported first half figures today
Investments and investor services
Accesso, which takes the waiting out of queuing at theme parks, cheered investors today by raising profits guidance.
First Coast’s jurisdiction includes Florida, Puerto Rico and the US Virgin Islands and increases the number of potential patients for Dermapure by 2.5mln.
Investments and investor services
A round-up of the day's news from growth companies.
The agreement is for one of twelve states covered by Novitas, one of the administrators of Medicare.
Archive
The full weight of the Greek saga made its presence felt on Footsie at the close....
Archive
FTSE100 was 53 points lower at 6,755 as the Greece saga rumbled on.
“In the space of just four months the product has gained approval for coverage in over half of the American states."
FTSE 100 ends lower as reaches last chance saloon - again...
Majors need new products to stay relevant to large US hospitals said Jefferies.
Archive
It is not often you see the word bonanza written in a company’s report but it happened today.
DermaPure was among the medical developments discussed by a US specialist in wound and hyberbaric medicine on a US TV show.